Inovio, which is based in Plymouth Meeting, Pennsylvania, and GeneOne Life Science, which is based in Seoul, South Korea, worked together on the vaccine. They previously collaborated to create vaccines for Ebola and MERS, both of which are being tested.
The Zika vaccine GLS-5700, will first be tested in 40 healthy volunteers. The first tests in humans should start in the next few weeks
The zika virus vaccine will soon be given to children and adults as soon as its approved for usage and may be mandatory for all people.